When it comes to NVDA… “acceleration cycles” are the key

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!

Heidi Chen Biography and Net Worth

EVP of Zoetis

Heidi C. Chen serves as Executive Vice President, General Counsel, Corporate Secretary of Zoetis Inc. Ms. Chen has served as our Executive Vice President and General Counsel since October 2012, and as our Corporate Secretary since July 2012. Ms. Chen was also given responsibility for our Human Health Diagnostics business in January 2020. Prior to Zoetis, Ms. Chen was Vice President and Chief Counsel of Pfizer Animal Health, our predecessor company, from 2009 to 2012. Ms. Chen joined Pfizer in 1998 and held various legal and compliance positions of increasing responsibility, including lead counsel for Pfizer’s Established Products (generics) business.

What is Heidi C. Chen's net worth?: The estimated net worth of Heidi C. Chen is at least $4.83 million as of September 15th, 2023. Ms. Chen owns 27,478 shares of Zoetis stock worth more than $4,827,060 as of November 21st. This net worth approximation does not reflect any other investments that Ms. Chen may own. Additionally, Ms. Chen receives a salary of $1,240,000.00 as EVP at Zoetis. Learn More about Heidi C. Chen's net worth.
How old is Heidi C. Chen?: Ms. Chen is currently 57 years old. There are 6 older executives and no younger executives at Zoetis. The oldest executive at Zoetis is Ms. Roxanne Lagano, EVP, Chief HR Officer & Global Operations, Interim General Counsel and Corporate Secretary, who is 59 years old. Learn More on Heidi C. Chen's age.
What is Heidi C. Chen's salary?: As the EVP of Zoetis Inc., Ms. Chen earns $1,240,000.00 per year. There are 3 executives that earn more than Ms. Chen. The highest earning executive at Zoetis is Ms. Kristin C. Peck, CEO & Director, who commands a salary of $3,540,000.00 per year. Learn More on Heidi C. Chen's salary.
How do I contact Heidi C. Chen?: The corporate mailing address for Ms. Chen and other Zoetis executives is 10 Sylvan Way, Parsippany NJ, 07054. Zoetis can also be reached via phone at (973) 822-7000 and via email at [email protected]. Learn More on Heidi C. Chen's contact information.
Has Heidi C. Chen been buying or selling shares of Zoetis?: Heidi C. Chen has not been actively trading shares of Zoetis over the course of the past ninety days. Most recently, Heidi C. Chen sold 9,905 shares of the business's stock in a transaction on Friday, September 15th. The shares were sold at an average price of $180.15, for a transaction totalling $1,784,385.75. Following the completion of the sale, the executive vice president now directly owns 27,478 shares of the company's stock, valued at $4,950,161.70. Learn More on Heidi C. Chen's trading history.
Who are Zoetis' active insiders?: Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Gregory Norden (Director), Kristin Peck (CEO), Robert Polzer (EVP), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.
Are insiders buying or selling shares of Zoetis?: In the last twelve months, insiders at the sold shares 6 times. They sold a total of 18,632 shares worth more than $3,346,903.01. The most recent insider tranaction occured on April, 18th when EVP Roxanne Lagano sold 923 shares worth more than $139,529.91. Insiders at Zoetis own 0.2% of the company. Learn More about insider trades at Zoetis.
Information on this page was last updated on 4/18/2024.

Heidi C. Chen Insider Trading History at Zoetis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/15/2023	Sell	9,905	$180.15	$1,784,385.75	27,478
11/9/2021	Sell	9,446	$220.00	$2,078,120.00
10/25/2021	Sell	9,446	$210.22	$1,985,738.12
4/21/2021	Sell	11,637	$170.14	$1,979,919.18	36,282
12/1/2020	Sell	1,180	$161.64	$190,735.20	17,515
11/2/2020	Sell	1,179	$161.43	$190,325.97	17,514
10/1/2020	Sell	1,179	$166.23	$195,985.17	17,514
9/1/2020	Sell	1,179	$160.71	$189,477.09	17,514
8/3/2020	Sell	1,179	$152.19	$179,432.01	17,514
7/1/2020	Sell	1,179	$137.29	$161,864.91	17,514
6/1/2020	Sell	1,179	$138.65	$163,468.35	17,514
5/1/2020	Sell	1,179	$127.44	$150,251.76	17,514
2/3/2020	Sell	1,179	$134.58	$158,669.82	12,642
1/21/2020	Sell	15,329	$139.81	$2,143,147.49	26,792
6/3/2019	Sell	2,500	$104.23	$260,575.00	11,463
3/12/2019	Sell	15,710	$95.49	$1,500,147.90	13,963
12/3/2018	Sell	2,500	$93.51	$233,775.00	17,662
3/16/2018	Sell	7,383	$84.71	$625,413.93	20,162
2/20/2018	Sell	37,453	$81.02	$3,034,442.06
9/1/2016	Sell	32,097	$50.98	$1,636,305.06	46,060

Heidi C. Chen Buying and Selling Activity at Zoetis

Zoetis Company Overview

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Today's Range

Now: $175.67

$173.83

$177.41

50 Day Range

MA: $186.18

$170.37

$196.48

2 Week Range

Now: $175.67

$144.80

$201.92

Volume

2,186,455 shs

Average Volume

2,913,613 shs

Market Capitalization

$79.26 billion

P/E Ratio

33.02

Dividend Yield

0.98%

Beta

0.9

When it comes to NVDA… “acceleration cycles” are the key

From DTI | Ad

Use this link to see Nvidia Unchained right away!

Heidi Chen Biography and Net Worth

What is Heidi C. Chen's net worth?

How old is Heidi C. Chen?

What is Heidi C. Chen's salary?

How do I contact Heidi C. Chen?

Has Heidi C. Chen been buying or selling shares of Zoetis?

Who are Zoetis' active insiders?

Are insiders buying or selling shares of Zoetis?